BillionToOne
NASDAQ: BLLNYC S17San Francisco, US · Founded 2016 · 300 employees · Public · Hiring · 22 known investors
BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection. The company focuses on making molecular diagnostics accurate, fast, and accessible to patients.
BiotechDigital HealthHealthtechMedical DevicesDiagnosticsGenomicsUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (S17)
BillionToOne was founded in 2016 by Oguzhan Atay, PhD, David Tsao, PhD, Oguzhan Atay, David Tsao, and Sukrit Silas.
OA
Oguzhan Atay, PhDCo-Founder, CEO, and Board ChairCo-founder & CEO of BillionToOne
DT
OA
SS
Sukrit SilasCofounder30 Under 30 2019
Investors · 22
500 Emerging EuropeAmsterdam
500 GlobalSan Francisco · $150K
Asymmetry VenturesRichmond · $125K – $500Kvia Rob Ness · inferred
Civilization Ventures Management, LlcTiburon · $1M – $10M
e2vc
Fifty YearsSan Francisco · $250K – $2M
FrialeNashville · $100K – $600Kvia Bryan Frist · inferred
Hemisphere Ventures LLCMckinney
HOF CapitalNew York · $25K – $15M
Hummingbird VenturesSingapore · $500K – $10M
MetaplanetTallinn · $500K – $10M
Neotribe VenturesMenlo Park · $250K – $2M
Norwest Venture PartnersMenlo Park · $10M – $30M
Oberland CapitalNew York · $50M – $300M
Premji InvestMenlo Park
Standard CapitalSan Francisco
Start Capital
Time BioVenturesSouthern California
Toba CapitalIrvine · $1M – $10M
UpHonest CapitalSilicon Valley · $50K – $1M
Y CombinatorSan Francisco · $500K
Lombardstreet VenturesreportedWoodside · $500K
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through BillionToOne went on to found or lead other companies.
Competitors · 3
by search overlapLabcorp113 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Natera59 shared keywordsNatera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions. The company serves patients, physicians, and healthcare systems across oncology, women's health, and organ health.
Quest Diagnostics50 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Companies competing with BillionToOne for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does BillionToOne do?
- BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection. The company focuses on making molecular diagnostics accurate, fast, and accessible to patients.
- Who founded BillionToOne?
- BillionToOne was founded by Oguzhan Atay, PhD, David Tsao, PhD, Oguzhan Atay, David Tsao, Sukrit Silas in 2016.
- Who are BillionToOne's investors?
- BillionToOne's investors include 500 Emerging Europe, 500 Global, Asymmetry Ventures, Civilization Ventures Management, Llc, e2vc, Fifty Years, Friale, Hemisphere Ventures LLC and 14 more.
- Is BillionToOne publicly traded?
- Yes — BillionToOne trades on NASDAQ under the ticker BLLN.
- Where is BillionToOne headquartered?
- BillionToOne is headquartered in San Francisco, US.